Full Text View
Tabular View
No Study Results Posted
Related Studies
Mastoid Bone Autograft for Dorsal Nasal Augmentation
This study has been completed.
First Received: October 16, 2007   Last Updated: February 3, 2009   History of Changes
Sponsored by: Federal University of Uberlandia
Information provided by: Federal University of Uberlandia
ClinicalTrials.gov Identifier: NCT00545428
  Purpose

The purpose of this study is to evaluate the safety and efficacy of mastoid bone autograft for dorsal nasal augmentation in rhinoplasty.


Condition Intervention
Nose Deformities, Acquired
Procedure: Rhinoplasty

U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Single Blind (Outcomes Assessor), Single Group Assignment, Safety/Efficacy Study
Official Title: Mastoid Bone Autograft for Dorsal Nasal Augmentation

Further study details as provided by Federal University of Uberlandia:

Primary Outcome Measures:
  • Patient's satisfaction [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Observer's satisfaction [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Enrollment: 15
Study Start Date: April 2006
Study Completion Date: December 2008
Primary Completion Date: July 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
Rhinoplasty
Procedure: Rhinoplasty
Mastoid bone autograft for dorsal nasal augmentation

Detailed Description:

INTRODUCTION: Several grafts and/or implants have been used for dorsal augmentation. In some cases, especially the traumatic, non-caucasian, and multi-operated ones, the amount of augmentation is higher than the usually available from septal and auricular conchal autografts.

OBJECTIVE: To evaluate the safety and efficacy of mastoid bone autograft for dorsal nasal augmentation in rhinoplasty.

DESIGN: A prospective study of 15 consecutive patients submitted to dorsal nasal augmentation with mastoid bone, during a 2-year period.

SETTING: One major academic medical center.

  Eligibility

Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Nasal acquired or congenital deformity of the dorsum that requires augmentation of more than 5 mm

Exclusion Criteria:

  • Previous otologic surgery/disease
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00545428

Locations
Brazil, mg
Federal University of Uberlandia, Department of ENT/H&N
Uberlandia, mg, Brazil, 38400-368
Sponsors and Collaborators
Federal University of Uberlandia
Investigators
Principal Investigator: Lucas G Patrocinio, MD Federal University of Uberlandia, Department of ENT/H&N
Study Chair: Jose A Patrocinio, MD, PhD Federal University of Uberlandia, Department of ENT/H&N
  More Information

Publications:
Responsible Party: Federal University of Uberlandia ( Lucas Gomes Patrocinio )
Study ID Numbers: 1-Patrocinio
Study First Received: October 16, 2007
Last Updated: February 3, 2009
ClinicalTrials.gov Identifier: NCT00545428     History of Changes
Health Authority: Brazil: National Committee of Ethics in Research

Keywords provided by Federal University of Uberlandia:
Nasal acquired diseases
Nasal congenital diseases
Rhinoplasty
Grafts

Study placed in the following topic categories:
Nose Deformities, Acquired
Otorhinolaryngologic Diseases
Respiratory Tract Diseases
Congenital Abnormalities

Additional relevant MeSH terms:
Nose Deformities, Acquired
Otorhinolaryngologic Diseases
Respiratory Tract Diseases
Nose Diseases

ClinicalTrials.gov processed this record on May 06, 2009